Mesenchymal stem cells (MSCs) play a crucial role in angiogenesis associated with multiple myeloma, mainly by secreting pro-angiogenic factors like vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2). This evidence concerns the gene FGF2 and AL amyloidosis.